Analysis of Somatic Mutations and Immunotherapy Biomarkers in Chinese Patients With Non‐Small Cell Lung Cancer During 2019–2024: A Retrospective Study
Xiumei Liu(Dalian University of Foreign Languages), J Q Liu(Dalian University of Foreign Languages), Weigong Chen(Stem Cell Institute), Wang Zexu(Dalian Medical University), Kaiyu Yi(Dalian Medical University), Liang Wang(Dalian University of Foreign Languages), Chengqi Xin(Dalian University of Foreign Languages)
Cited by 0
Related Papers
Trends of foodborne diseases in China: lessons from laboratory-based surveillance since 2011
|Frontiers of Medicine|2017|156
Population ageing, labour market rigidity and corporate innovation: Evidence from China
|Research Policy|2021|109
LncRNA SNHG16 Functions as an Oncogene by Sponging MiR-4518 and Up-Regulating PRMT5 Expression in Glioma
|Cellular Physiology and Biochemistry|2018|104
USP10 suppresses tumor progression by inhibiting mTOR activation in hepatocellular carcinoma
|Cancer Letters|2018|98
Density and Surface Tension of Ionic Liquids [C<sub><i>n</i></sub>py][NTf<sub>2</sub>] (<i>n</i> = 2, 4, 5)
|Journal of Chemical & Engineering Data|2010|85